While GLP-1 agonists are certainly effective, #bariatric surgery remains superior in weight loss, disease progression prevention, and loss of lives.

How can NHS justify restricting access to #MetabolicSurgery while investing in a big roll-out of a much less effective #VLCD weight management program for diabetes remissions? #WeightBias guides the way. conscienhealth.org/2024/07/the-di…

I’m excited for the free regional OAC Your Weight Matters meeting in Boston this weekend. Honored to be speaking about stress reduction and weight loss. Angela Fitch,MD will be speaking as well. One of my favorite organizations advocating for those with obesity. ASMBS

This year’s Great North Pharmacy Research Collaborative Conference focused on rewriting the narrative on women's health. See all the wonderful work showcased at the event here 👇 flipsnack.com/F9BCC7BBDC9/gn…

Fantastic conclusion to a productive day of discussions on cholecystectomies, bile duct injuries, and more. The day ended on a high note with the launch of the National Bile Duct Injury Registry! #CholecystectomySummit #BDI

Persons with #OpioidUseDisorder and #T2D are MUCH less likely to have a drug overdose if they get #semaglutide. This big difference in outcomes needs more research. conscienhealth.org/2024/10/might-…

Might Semaglutide Lower the Risk of Opioid Overdoses? - ⁦Ted Kyle⁩ conscienhealth.org/2024/10/might-…

The GLP-1 discovery and translation story-how did it happen? #diabetes #obesity #heartdisease cell.com/med/fulltext/S…

NEW: we may have passed peak obesity 🎉📈📉🙏 In what might be one of the most significant trends I have ever charted, the US obesity rate fell last year.

We already know from clinical trials that Ozempic and other GLP-1 drugs produce sustained reductions in body weight, but with mass public usage taking off — one in eight US adults have used the drugs — the results may now be showing up at population level.

While we can’t be certain that the new generation of drugs are behind this reversal, it is highly likely. For one, the decline in obesity is steepest among college graduates, the group using them at the highest rate.

We're excited to be growing our operations team: 💼ASO Operations Secretary 💼ASO Sponsorship Role 💼ASO Early Career Research Team 💼ASO Centres for Obesity Management (COMs) Team. 💼UKCO Team Ready to make a difference? Learn more & apply here👇🏽 aso.org.uk/news/opportuni…

Don't miss the next Overprescribing Community of Practice on the 24th Oct! We'll be joined by Charlotte Scott, Senior Clinical Pharmacist at NorthumbriaNHS, who will share highlights from a Parkinson's Disease Quality Improvement project. Register 👉 eventbrite.co.uk/e/nenc-overpre…

Maybe we have reached a peak on obesity rates in 🇺🇸 🤷🏻‍♂️

A great opportunity to become more involved with Association for the Study of Obesity UK

Until now, the gut microbiome hasn't been used to make clinical diagnoses. That may change. A new report on its utility for non-invasively diagnosing inflammatory bowel disease. nature.com/articles/s4159… Nature Medicine Siew Ng

Don’t miss out on an unforgettable ASMBS 2024 Weekend in the heart of Atlanta! 🎉 Secure your hotel room at the Atlanta Marriott Marquis by October 8, 2024, through our exclusive link to take advantage of a special event rate! 🏨✨ ow.ly/JHAw50TCn7l

Is there a 'rebound' effect when stopping #GLP1RA? I have a patient who omitted one injection during her holiday and has struggled to lose weight since...

At OAC Your Weight Matters Boston. Angela Fitch,MD leading off with the underpinnings of #obesity. To paraphrase James Carville, “It’s the biology, stupid!”

It was a joy to share the stage with you Angela Fitch,MD on behalf of OAC. What a great day! Look for more to come.